In the case of several cancers (e.g., ovarian, gastric and breast tumors), a diminished level of HtrA1 protein in tumor tissue has been correlated with poor response to platinum-based chemotherapy, metastasis, and worse clinical outcome [13,14,15,16,17,18]. This evidence concerns the gene HTRA1 and neoplasm.